• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 MESH-VENTRALEX; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 MESH-VENTRALEX; SURGICAL MESH Back to Search Results
Catalog Number 0010303
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Seroma (2069); Post Operative Wound Infection (2446)
Event Date 11/06/2011
Event Type  Injury  
Manufacturer Narrative
As reported post implant of the ventralex mesh, the patient developed surgical site infection, underwent percutaneous aspiration of infectious seroma and prescribed with oral antibiotics.The clinician has assessed the patient¿s postoperative course as being ¿possibly¿ related to the study device and possibly related to the procedure, however, based on the information provided, no conclusion can be made.Post operative infection and seroma formation are known inherent risks of surgery.The instructions-for-use (ifu) supplied with the device lists infection and seroma as possible complications.In regards to infection, the warning section of the ifu states, "if an infection develops, treat the infection aggressively.Consideration should be given regarding the need to remove the patch.An unresolved infection may require removal of the device." a lot number was not provided, without a lot number a review of the manufacturing records could not be conducted.Not returned - remains implanted.
 
Event Description
Reported per clinical trial (b)(4): on (b)(6) 2011 - subject patient underwent open midline umbilical repair and lysis of adhesions during which a bard/davol ventralex hernia patch was implanted with mechanical sutures.Fascia and full skin closure was achieved using non-bard/davol prolene and surgical glue.The patient was discharged to home on (b)(6) 2011.On (b)(6) 2011 - subject patient was diagnosed with surgical site infection, was treated with oral antibiotics and percutaneous aspiration of infectious seroma at the surgical site in the clinic.Per the study clinician, the reported adverse event has been assessed as mild in severity, possibly related to the study device and possibly related to the index procedure.The outcome for this ae is reported as recovered/resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MESH-VENTRALEX
Type of Device
SURGICAL MESH
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
BARD SHANNON LIMITED -3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key14434827
MDR Text Key292028335
Report Number1213643-2022-00237
Device Sequence Number1
Product Code FTL
UDI-Device Identifier00801741016486
UDI-Public(01)00801741016486
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K132441
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Study,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/19/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number0010303
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexMale
Patient Weight97 KG
-
-